S. no. | Study | Gene studied | Animal | Outcome | References |
---|---|---|---|---|---|
1 | KO | CLOCK | Mice | Hypertension | [120] |
2 | KO | CLOCK | Mice | Mild diabetes insipidus | [121] |
3 | KO | Per1 | Mice | Lower blood pressure | [122] |
4 | Double KO | Cry1/2 | Mice | Hypertension | [123] |
5 | KO | BMAL1 | Mice | Reduced blood pressure | [124] |
6 | Mutant | CLOCK | Mice | Obesity and hyperlipidemia | [19] |
7 | Triple KO | Period 1/2/3 | Mice | Obesity | [125] |
8 | KO | BMAL1 | Mice | Obesity and hyperlipidemia | [126] |
9 | KO | REV-ERB-γ | Mice | Increased adiposity and deregulated fatty acid/glucose utilization | [127] |
10 | Double KO | REV-ERB-α/ β | Mice | Deregulation lipid metabolism | [128] |
11 | KO | BMAL1 and CLOCK | Mice | Diabetic with reduced plasma insulin levels | [12] |
12 | SNPs | Bmal1 | Human | Gestational diabetes mellitus | [129] |
13 | KO | BMAL1 | Mice | Reduced plasma insulin levels | [130] |
14 | KO | Pancreas-specific BMAL1 | Mice | Hyperglycaemia | [12] |
15 | KO | Cry1/2 | Mice | Hyperglycemia | [131] |
16 | Adrenalectomy | Per1 | Mice | Reduce glucocorticoid signalling | [132] |
17 | KO | Per1 | Mice | Higher plasma and pineal melatonin | [133] |
18 | Melatonin intervention | - | Human prostate cancer cells | Increased expression of Per1 and CLOCK, decreased BMAL1 | [134] |
19 | Mutant | Per2 | Mice | TLR9 upregulated in spleen | [135] |
20 | KO | Cry1/2 | Mice | Upregulation (NF)-κB | [136] |
21 | KO | BMAL1 | Mice | Decreased fertility and implantation defects | [137] |
22 | KO | CLOCK | Mice | Decreased fertility | [138] |
23 | TRF (10 h/day for 12 weeks) intervention | – | Human | Reduced body weight, visceral fat, lowered blood pressure and decreased HbA1c | [139] |